Analysen von Michael Leuchten
27.09.18 | GSK buy | UBS AG | |
18.09.18 | Bayer buy | UBS AG | |
05.09.18 | Bayer buy | UBS AG | |
30.08.18 | Bayer buy | UBS AG | |
17.08.18 | Bayer buy | UBS AG | |
09.08.18 | Merck buy | UBS AG | |
08.08.18 | Novo Nordisk buy | UBS AG | |
03.08.18 | GSK buy | UBS AG | |
Werbung
|
|||
30.07.18 | GSK buy | UBS AG | |
26.07.18 | GSK buy | UBS AG | |
25.07.18 | Novo Nordisk buy | UBS AG | |
25.07.18 | GSK buy | UBS AG | |
23.07.18 | GSK buy | UBS AG | |
02.07.18 | GSK buy | UBS AG | |
26.06.18 | Bayer buy | UBS AG | |
26.06.18 | Merck buy | UBS AG | |
25.06.18 | Novo Nordisk buy | UBS AG | |
14.06.18 | GSK buy | UBS AG | |
14.06.18 | Novo Nordisk buy | UBS AG | |
08.06.18 | Novo Nordisk buy | UBS AG | |
06.06.18 | Bayer buy | UBS AG | |
31.05.18 | Bayer buy | UBS AG | |
30.05.18 | Novo Nordisk buy | UBS AG | |
30.05.18 | Bayer buy | UBS AG | |
25.05.18 | GSK buy | UBS AG | |
17.05.18 | Merck buy | UBS AG | |
15.05.18 | Merck buy | UBS AG | |
03.05.18 | Bayer buy | UBS AG | |
03.05.18 | Novo Nordisk buy | UBS AG | |
02.05.18 | Novo Nordisk buy | UBS AG | |
26.04.18 | GSK buy | UBS AG | |
25.04.18 | Novo Nordisk buy | UBS AG | |
05.04.18 | GSK buy | UBS AG | |
04.04.18 | Merck Buy | UBS AG | |
27.03.18 | GSK buy | UBS AG | |
27.03.18 | Novo Nordisk buy | UBS AG | |
22.03.18 | Bayer buy | UBS AG | |
12.03.18 | Merck buy | UBS AG | |
08.03.18 | Merck buy | UBS AG | |
28.02.18 | Bayer buy | UBS AG | |
19.02.18 | Novo Nordisk buy | UBS AG | |
16.02.18 | Merck buy | UBS AG | |
14.02.18 | Bayer buy | UBS AG | |
12.02.18 | Bayer buy | UBS AG | |
08.02.18 | GSK buy | UBS AG | |
07.02.18 | Novo Nordisk buy | UBS AG | |
02.02.18 | Novo Nordisk buy | UBS AG | |
01.02.18 | Novo Nordisk buy | UBS AG | |
15.01.18 | Novo Nordisk buy | UBS AG | |
15.01.18 | Merck buy | UBS AG |